Logo image of LIEN

CHICAGO ATLANTIC BDC INC (LIEN) Stock Fundamental Analysis

NASDAQ:LIEN - Nasdaq - US8281741020 - Common Stock - Currency: USD

10.445  +0.01 (+0.05%)

Fundamental Rating

5

Overall LIEN gets a fundamental rating of 5 out of 10. We evaluated LIEN against 237 industry peers in the Capital Markets industry. While LIEN has a great health rating, its profitability is only average at the moment. LIEN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LIEN had positive earnings in the past year.
In the past year LIEN has reported a negative cash flow from operations.
LIEN Yearly Net Income VS EBIT VS OCF VS FCFLIEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

LIEN's Return On Assets of 5.33% is fine compared to the rest of the industry. LIEN outperforms 73.00% of its industry peers.
LIEN has a worse Return On Equity (5.55%) than 60.34% of its industry peers.
With a decent Return On Invested Capital value of 5.35%, LIEN is doing good in the industry, outperforming 63.71% of the companies in the same industry.
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROIC 5.35%
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LIEN Yearly ROA, ROE, ROICLIEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50

1.3 Margins

LIEN has a Profit Margin of 54.23%. This is amongst the best in the industry. LIEN outperforms 94.51% of its industry peers.
LIEN has a better Operating Margin (66.22%) than 98.73% of its industry peers.
LIEN has a better Gross Margin (77.36%) than 83.12% of its industry peers.
Industry RankSector Rank
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
LIEN Yearly Profit, Operating, Gross MarginsLIEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

7

2. Health

2.1 Basic Checks

The number of shares outstanding for LIEN has been increased compared to 1 year ago.
LIEN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LIEN Yearly Shares OutstandingLIEN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
LIEN Yearly Total Debt VS Total AssetsLIEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 11.62 indicates that LIEN is not in any danger for bankruptcy at the moment.
LIEN has a Altman-Z score of 11.62. This is amongst the best in the industry. LIEN outperforms 93.67% of its industry peers.
There is no outstanding debt for LIEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.62
ROIC/WACCN/A
WACCN/A
LIEN Yearly LT Debt VS Equity VS FCFLIEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.96 indicates that LIEN should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.96, LIEN is in the better half of the industry, outperforming 67.93% of the companies in the same industry.
A Quick Ratio of 1.96 indicates that LIEN should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.96, LIEN is doing good in the industry, outperforming 68.35% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.96
LIEN Yearly Current Assets VS Current LiabilitesLIEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1412.33% over the past year.
LIEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 119229.00%.
EPS 1Y (TTM)1412.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)119229%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%324.5%

3.2 Future

LIEN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.33% yearly.
The Revenue is expected to grow by 76.50% on average over the next years. This is a very strong growth
EPS Next Y-27.55%
EPS Next 2Y17.49%
EPS Next 3Y13.33%
EPS Next 5YN/A
Revenue Next Year72.4%
Revenue Next 2Y116.15%
Revenue Next 3Y76.5%
Revenue Next 5YN/A

3.3 Evolution

LIEN Yearly Revenue VS EstimatesLIEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 20M 40M 60M
LIEN Yearly EPS VS EstimatesLIEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.14, the valuation of LIEN can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of LIEN indicates a somewhat cheap valuation: LIEN is cheaper than 74.26% of the companies listed in the same industry.
LIEN is valuated cheaply when we compare the Price/Earnings ratio to 26.93, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.07, the valuation of LIEN can be described as very cheap.
Based on the Price/Forward Earnings ratio, LIEN is valued cheaper than 91.56% of the companies in the same industry.
LIEN is valuated cheaply when we compare the Price/Forward Earnings ratio to 35.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.14
Fwd PE 7.07
LIEN Price Earnings VS Forward Price EarningsLIEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LIEN Per share dataLIEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

LIEN's earnings are expected to grow with 13.33% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.49%
EPS Next 3Y13.33%

5

5. Dividend

5.1 Amount

LIEN has a Yearly Dividend Yield of 12.20%, which is a nice return.
Compared to an average industry Dividend Yield of 7.82, LIEN pays a better dividend. On top of this LIEN pays more dividend than 81.43% of the companies listed in the same industry.
LIEN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.39.
Industry RankSector Rank
Dividend Yield 12.2%

5.2 History

LIEN has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
LIEN Yearly Dividends per shareLIEN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

65.00% of the earnings are spent on dividend by LIEN. This is not a sustainable payout ratio.
DP65%
EPS Next 2Y17.49%
EPS Next 3Y13.33%
LIEN Yearly Income VS Free CF VS DividendLIEN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 2024 0 5M -5M 10M
LIEN Dividend Payout.LIEN Dividend Payout, showing the Payout Ratio.LIEN Dividend Payout.PayoutRetained Earnings

CHICAGO ATLANTIC BDC INC

NASDAQ:LIEN (8/15/2025, 10:09:47 AM)

10.445

+0.01 (+0.05%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-05 2025-11-05/amc
Inst Owners21.3%
Inst Owner ChangeN/A
Ins Owners0.34%
Ins Owner Change0.06%
Market Cap238.35M
Analysts43.33
Price Target12.38 (18.53%)
Short Float %0.12%
Short Ratio0.58
Dividend
Industry RankSector Rank
Dividend Yield 12.2%
Yearly Dividend0.86
Dividend Growth(5Y)N/A
DP65%
Div Incr Years0
Div Non Decr Years0
Ex-Date06-27 2025-06-27 (0.34)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.93%
Min EPS beat(2)7.53%
Max EPS beat(2)18.32%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)6.83%
Min Revenue beat(2)0.94%
Max Revenue beat(2)12.73%
Revenue beat(4)4
Avg Revenue beat(4)28.82%
Min Revenue beat(4)0.94%
Max Revenue beat(4)53.37%
Revenue beat(8)8
Avg Revenue beat(8)18.11%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)27.86%
EPS NY rev (1m)0%
EPS NY rev (3m)30.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)22.27%
Revenue NY rev (1m)0%
Revenue NY rev (3m)10.36%
Valuation
Industry RankSector Rank
PE 10.14
Fwd PE 7.07
P/S 7.73
P/FCF N/A
P/OCF N/A
P/B 0.79
P/tB 0.79
EV/EBITDA N/A
EPS(TTM)1.03
EY9.86%
EPS(NY)1.48
Fwd EY14.14%
FCF(TTM)-0.63
FCFYN/A
OCF(TTM)-0.63
OCFYN/A
SpS1.35
BVpS13.19
TBVpS13.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 5.55%
ROCE 6.78%
ROIC 5.35%
ROICexc 5.63%
ROICexgc 5.63%
OM 66.22%
PM (TTM) 54.23%
GM 77.36%
FCFM N/A
ROA(3y)3.58%
ROA(5y)N/A
ROE(3y)3.7%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.96
Quick Ratio 1.96
Altman-Z 11.62
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1412.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y-27.55%
EPS Next 2Y17.49%
EPS Next 3Y13.33%
EPS Next 5YN/A
Revenue 1Y (TTM)119229%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%324.5%
Revenue Next Year72.4%
Revenue Next 2Y116.15%
Revenue Next 3Y76.5%
Revenue Next 5YN/A
EBIT growth 1Y155.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-187.57%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-187.57%
OCF growth 3YN/A
OCF growth 5YN/A